S&P 500
(-0.88%) 4 967.23 points
Dow Jones
(0.56%) 37 986 points
Nasdaq
(-2.05%) 15 282 points
Oil
(0.62%) $83.24
Gas
(0.17%) $1.760
Gold
(0.36%) $2 406.70
Silver
(1.29%) $28.75
Platinum
(-1.17%) $943.30
USD/EUR
(-0.14%) $0.938
USD/NOK
(-0.21%) $11.02
USD/GBP
(0.56%) $0.808
USD/RUB
(-0.95%) $93.01

Realtime updates for PerkinElmer Inc [PKI]

Exchange: NYSE Sector: Healthcare Industry: Diagnostics & Research
Last Updated15 May 2023 @ 16:03

-0.91% $ 115.24

Live Chart Being Loaded With Signals

Commentary (15 May 2023 @ 16:03):

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics...

Stats
Today's Volume 1.63M
Average Volume 808 389
Market Cap 14.46B
EPS $0 ( 2024-02-12 )
Next earnings date ( $0 ) 2024-05-09
Last Dividend $0.0700 ( 2023-07-20 )
Next Dividend $0 ( N/A )
P/E 41.45
ATR14 $3.13 (2.60%)
Insider Trading
Date Person Action Amount type
2023-12-15 Gonzales Anita Buy 248 Common Stock
2023-12-15 Gonzales Anita Buy 706 NQ Stock Option (right to buy)
2023-11-27 Michas Alexis P Sell 250 Common Stock
2023-11-28 Michas Alexis P Sell 230 Common Stock
2023-06-15 Gonzales Anita Buy 329 Common Stock
INSIDER POWER
28.73
Last 100 transactions
Buy: 270 652 | Sell: 165 378

Volume Correlation

Long: -0.22 (neutral)
Short: -0.12 (neutral)
Signal:(41.494) Neutral

PerkinElmer Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PerkinElmer Inc Correlation - Currency/Commodity

The country flag -0.76
( moderate negative )
The country flag -0.59
( weak negative )
The country flag -0.46
( neutral )
The country flag 0.29
( neutral )
The country flag 0.05
( neutral )
The country flag 0.32
( neutral )

PerkinElmer Inc Financials

Annual 2022
Revenue: $3.31B
Gross Profit: $1.99B (60.08 %)
EPS: $4.59
Q2 2023
Revenue: $709.07M
Gross Profit: $434.50M (61.28 %)
EPS: $0.280
Q1 2023
Revenue: $674.87M
Gross Profit: $381.37M (56.51 %)
EPS: $0.200
Q4 2022
Revenue: $741.21M
Gross Profit: $436.33M (58.87 %)
EPS: $0.850

Financial Reports:

No articles found.

PerkinElmer Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0700
(N/A)
$0.0700
(N/A)
$0.0700
(N/A)
$0.0700
(N/A)
$0.0700
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

PerkinElmer Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 9.51 - good (95.12%) | Divividend Growth Potential Score: 4.25 - Stable (15.10%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0225 1983-04-18
Last Dividend $0.0700 2023-07-20
Next Dividend $0 N/A
Payout Date 2023-08-11
Next Payout Date N/A
# dividends 164 --
Total Paid Out $10.25 --
Avg. Dividend % Per Year 0.11% --
Score 4.61 --
Div. Sustainability Score 9.51
Div.Growth Potential Score 4.25
Div. Directional Score 6.88 --
Next Divdend (Est)
(2024-07-01)
$0.0705 Estimate 22.45 %
Dividend Stability
0.60 Average
Dividend Score
4.61
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
1983 $0.0675 1.00%
1984 $0.100 1.24%
1985 $0.120 1.52%
1986 $0.130 1.36%
1987 $0.140 1.98%
1988 $0.150 1.78%
1989 $0.170 2.38%
1990 $0.190 2.20%
1991 $0.210 2.66%
1992 $0.245 2.03%
1993 $0.325 3.27%
1994 $0.280 3.15%
1995 $0.350 4.79%
1996 $0.280 2.35%
1997 $0.280 2.82%
1998 $0.280 2.68%
1999 $0.280 1.94%
2000 $0.280 1.35%
2001 $0.280 0.58%
2002 $0.280 0.80%
2003 $0.280 3.17%
2004 $0.280 1.60%
2005 $0.280 1.27%
2006 $0.280 1.17%
2007 $0.280 1.28%
2008 $0.280 1.10%
2009 $0.280 1.98%
2010 $0.280 1.36%
2011 $0.280 1.08%
2012 $0.280 1.36%
2013 $0.280 0.87%
2014 $0.280 0.68%
2015 $0.280 0.64%
2016 $0.280 0.53%
2017 $0.280 0.53%
2018 $0.280 0.38%
2019 $0.280 0.36%
2020 $0.280 0.28%
2021 $0.280 0.19%
2022 $0.280 0.15%
2023 $0.210 0.15%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
SJT Dividend Royal 2023-11-29 Monthly 39 12.52% 8.50
ZTR Dividend King 2024-02-09 Monthly 37 8.35% 8.50
SRV Dividend Royal 2023-12-04 Monthly 18 7.53% 8.50
PHK Dividend Royal 2023-11-10 Monthly 22 6.88% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
GOF Dividend Royal 2023-11-14 Monthly 18 8.03% 8.50
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50
PVL Dividend Royal 2023-11-15 Monthly 14 9.37% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.08931.5008.2110.00[0 - 0.5]
returnOnAssetsTTM0.01781.2009.4110.00[0 - 0.3]
returnOnEquityTTM0.03341.500-0.740-1.111[0.1 - 1]
payoutRatioTTM0.105-1.0008.95-8.95[0 - 1]
currentRatioTTM2.580.8002.111.689[1 - 3]
quickRatioTTM1.9740.8003.102.48[0.8 - 2.5]
cashRatioTTM0.9741.5005.708.55[0.2 - 2]
debtRatioTTM0.317-1.5004.72-7.08[0 - 0.6]
interestCoverageTTM4.841.0009.329.32[3 - 30]
operatingCashFlowPerShareTTM2.892.009.0410.00[0 - 30]
freeCashFlowPerShareTTM2.412.008.7910.00[0 - 20]
debtEquityRatioTTM0.573-1.5007.71-10.00[0 - 2.5]
grossProfitMarginTTM0.5851.0003.593.59[0.2 - 0.8]
operatingProfitMarginTTM0.1321.0009.359.35[0.1 - 0.6]
cashFlowToDebtRatioTTM0.08041.000-0.664-0.664[0.2 - 2]
assetTurnoverTTM0.2000.800-2.00-1.603[0.5 - 2]
Total Score9.51

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM57.061.0004.340[1 - 100]
returnOnEquityTTM0.03342.50-0.476-1.111[0.1 - 1.5]
freeCashFlowPerShareTTM2.412.009.2010.00[0 - 30]
dividendYielPercentageTTM0.1211.5006.960[0 - 0.4]
operatingCashFlowPerShareTTM2.892.009.0410.00[0 - 30]
payoutRatioTTM0.1051.5008.95-8.95[0 - 1]
pegRatioTTM-1.3131.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1281.0009.300[0.1 - 0.5]
Total Score4.25

PerkinElmer Inc

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators